The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials
Author:
Affiliation:
1. Pre-clinical R&D, Phoenix Molecular Designs, Vancouver, BC, Canada
2. Clinical Operations, Phoenix Molecular Designs, San Diego, CA, USA
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1818067
Reference66 articles.
1. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network
2. Molecular portraits of human breast tumours
3. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
4. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
5. The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo;Pharmacological Research;2023-10
2. Radiation Therapy in Patients with Germline Mutations: a Review of the Current Evidence;Current Breast Cancer Reports;2023-08-22
3. Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein;Cancer Cell International;2023-08-11
4. Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning;Frontiers in Pharmacology;2023-06-23
5. New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer;Diagnostics;2023-06-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3